ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

First-line Treatment With RC48 Plus Sintilimab and S-1 in Advanced Gastric Cancer (RCTS2)

Qilu Hospital of Shandong University · 2024
ClinicalTrials.gov · Datasets · License: Public Domain · 2024
Open Source ↗
her2-positive gastric cancer, metastatic gastric cancer, unresectable gastric carcinoma, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 868406
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.